Clinical trial
Validation of a Personalised Medicine Tool for Multiple Myeloma That Predicts Treatment Effectiveness in Patients
NCT03409692 is registered in ClinicalTrials.gov with Mario Boccadoro as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of a Personalised Medicine Tool for Multiple Myeloma That Predicts Treatment Effectiveness in Patients
- Lead sponsor
- Mario Boccadoro
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 14, 2017
- Completion date
- July 25, 2022
- Enrollment
- 278 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.